☆ 4.7 Meeting Abstract

A phase I study of the MDM2 inhibitor AMG 232 in patients with advanced p53 wild type (p53WT) solid tumors or multiple myeloma

EUROPEAN JOURNAL OF CANCER (2016)

Get Full Text
Add to Collection

Journal

EUROPEAN JOURNAL OF CANCER
Volume 69, Issue -, Pages S34-S34

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S0959-8049(16)32682-X

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.